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The high  frequency of T  lymphocytes recognizing allelic variants of major 
histocompatibility complex (MHC) l products has puzzled immunologists. More 
than 50%, and possibly all T  cells, recognize products of foreign MHC genes (1- 
3). Further studies have indicated that T  cells specific for complexes of conven- 
tional antigen and self-MHC products (4) also react with foreign MHC products 
(5-8). This has suggested that a high degree of homology between (a) complexes 
composed of an individual's own MHC  products and antigen, and (b) foreign 
MHC gene products, is responsible for alloreactivity. Another possibility is that 
receptors for foreign MHC products are distinct from receptors for complexes 
formed by an individual's MHC and foreign proteins (9). 
The first demonstration that a single clone of T  cells could recognize autolo- 
gous class  II  MHC products associated with antigen as well as foreign class  II 
MHC products, came from a  reaction of a  T  cell clone with specificity for (a) 
ovalbumin plus syngeneic I-A  k gene products and (b) I-A  ~  gene products (10).  A 
study of a  series of BALB/c  antiovalbumin  clones also  indicated that  several 
reacted  to  foreign  MHC  products,  and  that  these  reactions  were  randomly 
distributed among the foreign MHC haplotypes tested (1 1).  However, neither 
observation indicated whether or not "alloreactivity" included serum proteins 
in culture and, more importantly, whether this was due to binding by its receptor 
for conventional antigen and autologous MHC products. 
A  direct approach  to  this  requires a  panel  of cloned T  cells with  virtually 
identical specificities for a well-defined antigen and a particular self-MHC prod- 
uct. We shall term this physiologic reaction corecognition. If alloreactivity is, in 
fact, generated as a  direct consequence of the gene product(s) responsible for 
corecognition,  this  panel  should  display a  pronounced bias  of reactivity to  a 
particular foreign MHC product. We have tested this hypothesis and the results 
reported here indicate that a substantial number of clones with indistinguishable 
* Supported by grants  AI 13600, CA 26695, and AI 12184 from the National Institutes  of Health. 
J Abbreviations used in  this paper:  DME, Dulbecco's modified Eagle's medium; FCS, fetal calf 
serum; 2-ME, 2-mercaptoethanol;  MHC, major histocompatibility  complex. 
428  J. Exe. MED. © The Rockefeller  University  Press • 0022-1007/83/08/428/10  $1.00 
Volume 158  August  1983  428-437 ABROMSON-LEEMAN  AND CANTOR  429 
fine  specificities  for foreign  insulin  associated  with  the  I-A  b gene  product  also 
react with a  particular and unique foreign MHC gene product. 
Materials and  Methods 
Mice.  C57BL/10,  B10.A,  DBA/1,  ILn/J,  PL/J, SJL/J,  RIII/J, SM/J,  and B6AF~ 
mice were obtained from The Jackson Laboratory, Bar Harbor, ME.  Females between 
the ages of 6 and  10 weeks were used.  C3H.LG and B10.PL mice were kindly donated 
by Dr. M. Dorf, Pathology Department, Harvard Medical School. 
Antigens and hnmunizations.  Crystalline cow, sheep, and pig insulins were the generous 
gifts of Dr. R. E. Chance of the Lilly Research Laboratories, Indianapolis, IN. B chain of 
cow insulin was purchased from Sigma Chemical Co., St. Louis, MO. 
Antibodies.  The  following  affinity-purified  monoclonai  antibodies  were  generously 
donated by Dr. J. Freed and Dr. J. Kupinski, Johns Hopkins University School of Medicine: 
anti-I-A  k'" 10-3.6,  0.6  mg/ml; anti-I-E  k'"'v'a 14-4-4S,  1 mg/ml; anti-l-E  k 17-3-3S,  1 mg/ 
ml; anti-I-A  b 25-9-17,  1 mg/ml. Anti-I-A  b culture supernatants 28-16-8 and 25-9-3 were 
the kind gifts of Dr. D. Sachs, National Institutes of Health. 
Preparation  of conditioned  medium.  T  cell  growth  factor was  prepared by sequential 
treatment of B6AF1  spleen cells with neuraminidase and galactose oxidase according to 
the  method  of Novogrodsky and  Katchalski  (12).  Briefly, spleen  cell  suspensions  are 
incubated at a  concentration of 80 ×  106 celis/ml in 0.1  IU/ml neuraminidase (Calbi- 
ochem-Behring Corp., La Jolla, CA) for 30 min at 37°C, washed with phosphate-buffered 
saline and suspended in  10 U/ml galactose oxidase (Millipore Corp., Freehold, N  J) at a 
final concentration of 20 ×  106 cells/ml for 30 rain at room temperature. The cells were 
then washed and resuspended at a final concentration of 5 ×  10"cells/ml in (Dulbecco s 
modified Eagle's medium (DME) (Gibco Laboratories, Grand Island, NY) containing 4% 
fetal  calf serum  (FCS),  2  mM  L-glutamine  (Gibco  Laboratories) and  5  ×  10 -5  M  2- 
mercaptoethanol (2-ME).  Supernatants were collected 18-24 h later, centrifuged, filtered 
and stored at -20°C until use. 
Development and Maintenance of Antigen-specifc Clones.  2 wk after immunization of mice 
with cow or sheep insulin, draining  lymph nodes were removed. Cell suspensions were 
incubated in 25-cm  ~ flasks (3012; Falcon Labware, Oxnard, CA) at a concentration of 4 
×  106 cells/ml in Click's medium supplemented with 0.5% normal mouse serum, 4 mm 
L-glutamine, 2.5  mM sodium pyruvate (M.A. Bioproducts,  Walkersville, MD), 5  ×  10 -~ 
M 2-ME, and  100 #g/ml of the insulin used for immunization. 7 d later,  105 viable cells 
were incubated with 5 x  106 syngeneic irradiated (2,000 rad) spleen cells supplemented 
with 10% conditioned medium, 5% FCS, 4 mM L-glutamine, 5 ×  10  -5 M 2-ME, and 100 
ug/ml insulin  in a  Linbro well (Flow Laboratories, Inc., Hamden, CT).  Each week, an 
aliquot of 105 cells was removed and incubated with fresh irradiated spleen cells in cDME; 
antigen was added every other week. After 4-6 wk of growth, cells from these lines were 
cloned by limiting dilution. Cells were seeded into microtiter wells (Falcon 3040) contain- 
ing 106 irradiated feeder cells and 50 #g/ml antigen, in cDME. Within  10-14 d, growth 
was visible in  50%  of wells  seeded at 0.5  cell/well;  the cloned lines were expanded in 
Linbro wells and maintained in the same manner as the parent cell line. Cloned lines are 
supplemented every 2-3  d  with cDME containing 5-10%  conditioned medium. Clone 
C5, a C57BL6 anti-3-nitro-4-hydroxyphenyl acetyl (NP) clone, was donated by C. Clay- 
berger (Dana-Farber Cancer Institute) for this study. 
Assay for Antigen-specific [3H]thymidine Incorporation.  7-14 d after stimulation with fresh 
irradiated (2,000 rad) spleen cells with or without added antigen, the cloned cells were 
harvested, washed, and resuspended (104/0.2  ml) in DME containing 5% FCS, 4 mM L- 
glutamine, fi ×  10 -5 M 2-ME and 2.5 mM sodium pyruvate in microtiter wells containing 
5  ×  10 "~ irradiated  (2,000  rad)  spleen  cells  with  or without  different antigens.  Unless 
otherwise specified, 1 #Ci/well [SH]thymidine was added after 24 h and the cells harvested 
18 h  later using a  MASH (Bellco Glass, Inc., Vineland,  NJ).  Data is expressed as mean 
cpm incorporated ±  standard deviation of triplicate wells.  Inhibition of proliferation by 
monoclonal antibodies directed against various I region products of the MHC was assayed 
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Results 
10 different T  cell clones were initially tested for alloreactivity against a panel 
of nine MHC different target cells (Table I). Clones BC4, BC6, BC8, and BC10 
were derived from a  single cloning of a  C57BL/10 (B10) anti-cow insulin  cell 
line.  Clone C5  is a  C57BL/6 anti-NP  clone. Clone  AS7 is a  B10.A anti-sheep 
insulin clone. Clones AS6, AC4, AC7, and AC8 are all B10.A derived and are 
reactive to syngeneic (B10.A) spleen cells in  the presence of FCS.  Three  B10 
anti-cow insulin clones reacted to PL/J (H-2  u) target cells. The same three (out 
of four) clones that reacted to PL/J also showed a small, but significant, response 
to SM/J cells of the H-2  v haplotype. 
Clones BC4, BC6, BC8, and BC10 all react to cow insulin and not to sheep or 
pig insulin (Fig.  1). Since cow and sheep insulins differ from each other at only 
a single residue, position 9 of the A chain,  the specificity of these clones can be 
localized to the alpha loop of the insulin molecule. Moreover, all of these clones 
co-recognize cow insulin  associated with  I-A  b subregion products (not shown); 
thus, all four display identical or very similar antigen specificity. 
Because all four of these clones were derived from a single cell line, we could 
not exclude the possibility that BC4, BC6, and BC8 were daughter cells of one 
cell  in  the  line  that  also,  by random  chance,  reacted  to  PL/J.  Therefore,  we 
raised a second independent line of cow insulin specific cells from B 10 mice, and 
derived a  second panel of clones from this cell line.  Results of this cloning are 
shown in Table II. Of seven clones raised from B10 mice immune to cow insulin, 
six reacted with cow and not with any other insulin, and are thus specific for the 
alpha  loop of cow insulin.  Of these  six  clones,  two were alloreactive  to  PL/J 
spleen  cells  but  not  to  any  other  foreign  haplotype  tested  (not  shown).  The 
seventh clone, which is specific for B chain determinants of native insulin, showed 
no alloreactivity. An aliquot of cells from this same initial noncioned population 
was stimulated in vitro with the isolated B chain of cow insulin. All of the clones 
derived were specific for the denatured B chain of cow insulin (4/4), and none 
were reactive to PL/J or to any other MHC haplotype tested. Other  B10 cells 
were selected for reactivity to sheep insulin.  These were specific for the B chain 
TABLE  I 
Alloreactivity of Antigen-spec~c Clones 
Proliferative responses  ([SH]thymidine incorporation) of clones :~ 
Targets* 
BC4  BC6  BC8  BC10  C5  AS6  AS7  AC4  AC7  AC8 
C57BL/10!  464  373  402  750  646  171  310  652  1,655  565 
BI0.A  345  239  264  251  593  130  90,787  87,920  74,898  73,370 
DBA/1  1,259  954  NT  !  698  NT  810  829  486  375  558 
RIll  973  600  NT  326  NT  205  601  1,017  67  126 
SJL  1,317  985  NT  1,026  NT  847  923  740  1,030  430 
l/Ln  539  644  395  1,172  NT  270  NT  NT  NT  NT 
C3H.LG  1,299  628  NT  1,304  NT  1,108  1,102  737  951  771 
PL/J  37,719  49,119  75,399  1,198  672  257  1,484  276  1,261  374 
SM/J  3,705  4,425  9,707  1,287  NT  295  NT  NT  NT  NT 
Syngeneic plus antigen  50,443  54,399  116,527  21,446  12,857  76,593  .... 
* 5 x  l0  s irradiated (2,000  rad) spleen cells. 
2 x  104 cloned T  cells were  used  per well. Numbers represent the mean  of triplicate cultures.  Standard errors have been omitted for the 
sake of simplicity; all were <10% of the mean. 
H-2 haplotypes  are,  respectively,  b, a, q, r, s,j, f, u, and v. 
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FIGURE  1.  B 10 anti-cow insulin clones: 104 cells from each of four clones from the B 10 anti- 
cow insulin cell line were assayed for specificity and H-2 restriction. Either medium or  100 
vg/ml cow, sheep, or pig insulin was added. 5 x  105 irradiated (2,000 rad) syngeneic (B10) or 
allogeneic (B10.A) feeder cells were used. [3H]thymidine uptake was measured on day 2. 
TABLE  II 
Specificity and Alloreactivity of T Cells Derived  from Second Cloning 
[nH]thymidine incorporation* in response to: 
BI0 spleen cells* plus:  Clone* 
Cow  Sheep  PL/J  B10.A 
Medium  B chain  insulin  insulin 
BCC4  378  40,317  3,277  1,994  4~111  258 
BCC7  2,647  5~297  2,998  3,681  2~019  450 
BCC8  869  80,872  3,875  1,730  653  312 
BCCll  4,066  7~179  3,476  2,985  479  419 
BCC12  257  14,913  296  239  257  156 
BCC13  184  4,857  276  235  267  150 
BCC14  478  11,818  14,797  14,286  431  251 
BCB1  2,229  3,732  2,355  12~643  262  167 
BCB2  315  1,410  790  4~997  293  1,351 
BCB4  399  463  838  ROll  460  137 
BCB6  250  374  244  6,240  263  248 
BSS2  1,101  17,631  70,294  79,473  271  206 
BSS3  1,515  19,115  59,059  62,185  261  207 
* Means of triplicate cultures are shown. Standard errors are <10%. 
* 5  x  10  ~ irradiated (2,000  tad) spleen cells were  used  per well,  with medium 
antigen. 
From 104 to 2 x  104 cloned T  cells were cultured in each well. 
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of native insulin; none reacted with PL/J (or with other MHC haplotypes tested). 
A  summary of these data is presented in Table  III:  23  clones were tested for 
alloantigen recognition; 5 of 10 clones specific for the alpha loop of cow insulin 
reacted with PL/J cells. None of the remaining 13 clones that displayed related 
but not identical antigen specificities reacted with PL/J cells. 
To confirm that these reactions were properties of a  single cell, one of the 
TABLE  III 
Correlation of Antigen Spec~city and Alloreactivity to PL/J 
Number PL/J-reac- 
Specificity  tive clones/total 
B10 anti-cow insulin (A chain) 
B10 anti-cow insulin (B chain) 
B10 anti-sheep insulin (B chain) 
B 10 anti-B-chain (denatured) 
B6 anti-NP 
B10.A anti-sheep insulin (A chain) 
B10.A anti-'B10.A' 
5/10 
0/1 
0/2 
0/4 
0/1 
0/1 
0/4 
TABLE  IV 
Antigen Specificity and Alloreactivity of BC4 Subclones 
Clone 
[3H]thymidine incorporation in response to: 
B10* +  cow insulin*  PL/J* 
Parent BC4  51,313 ±  275  40,719 +  225 
BC4.BC.E9  §  32,254 +  2,829  24,382 +  1,407 
BC4.BC.D7  33,069 __. 572  25,395 +  1,209 
BC4.BC.D5  52,880 __. 854  41,094 +__ 572 
BC4.BC,D11  18,126 +  613  12,827 ±  244 
BC4.BC.F8  49,828 +  1,279  41,481  __. 521 
BC4.PL.C91  23,542 _  458  19,774 ___ 390 
BC4.PL.C5  54,234 +  4,585  31,844 +  3,906 
BC4.PL.C11  53,074 +  6,696  38,476 ±  1,818 
BC.PL.D7  18,870 ±  572  16,960 +  t,209 
* 5 x  105 irradiated (2,000 rad) spleen cells were used per culture. 
*  100  #g/ml insulin. Proliferation in  the absence of insulin for all  sub- 
clones is <100 cpm. 
Clones labeled BC4.BC. were subcloned on irradiated B10 spleen cells 
and cow insulin at 0.3 cells/well. 
!  Clones labeled BC4.PL.  were  subcloned on  PL/J  spleen cells at  0.3 
cells/well. 
TABLE  V 
Requirement for a Non-MHC Antigen of PL/J in Alloreaction 
[3H]thymidine incorporation in response to:* 
Clone 
C57BL10  B10.PL  PL/J 
BC4  4,196 +  500  736 +  768  175,121  _  1,014 
BC6  431  ±  92  812 _  379  51,499 +  7,287 
* 2  x  10  4 cloned T  cells were incubated with 5 x  105  irradiated (2,000 
rad) spleen cells from the indicated strains for 40 h. ABROMSON-LEEMAN  AND  CANTOR 
TABLE  VI 
Fine Specificity of  Atloantigen Recognition by Clone BC  4 
433 
Antibody* 
[SH]thymidine incorporation in response to:* 
Bt0 +  B10 + 
medium  cow insulin  ~  PL/J 
None  181  _+ 65  36,708 _+. 952  30,037 _  1,567 
Anti_l-A  TM 
1:50  192 -  53  30,919 --.+ 3,290  31,809 4- 3,091 
1:500  420 4- 27  34,070 -+ 931  29,789 + 65 
1:5000  147 +  37  27,386 -.+ 1,366  34,353 + 861 
Anti.I_E  k.u~ 
1:50  164 -+ 42  33,416 _+ 1,478  6,764 +_ 799 
1:500  262 +  44  34,529 "4" 2,565  8,804 ± 1,597 
1:5000  300 +  11  34,242 _+ 769  14,650 4- 1,558 
Anti-I-Ab** 
1:20  184 +  75  12,625 4- 1,629  30,877 _.+ 457 
Anti-I-Ek** 
1:50  245 4- 16  NT  34,335 4- 1,363 
1:500  185 4- 27  NT  27,096 4- 1,594 
* 104 T  cells were incubated with 5 x  105 irradiated (2,000 rad) spleen 
cells from B10 or PL/J strains for 40 h. 
* Antibody was added at the indicated final concentrations at initiation 
of cultures. 
100 #g/ml. 
I  Monoclonal antibody 10-3.6. 
¶ Monoclonal antibody 14-4-4S. 
** Monoclonal antibody 25-9-17. 
** Monoclonal antibody 17-3-3S. 
TABLE  VII 
Role of Specificity Ia. 7 (I-E) in Allorecognition 
T  cell 
clone*  Antibody* 
[SH]thymidine incorporation in response 
to spleen cells of: 
PL/J  SM/J 
BC4 
BC6 
BC8 
None  43,214 + 2,983  3,089 +  238 
Anti-I-A  u~  45,140 4- 1,707  4,883 4- 1,114 
Anti-I-E  u'vl  5,213 4- 1,454  600 4- 39 
None  11,227 4- 1,419  2,413 4- 77 
Anti-I-A  u  12,738 4- 1,496  3,279 _+ 523 
Anti-I-E  "'v  2,991 4- 140  498 4- 9 
None  83,468 :t= 612  7,000 4- 1,036 
Anti-I-A  u  85,568 4- 7,389  9,184 4- 1,292 
Anti-I-E  "'v  16,107 4- 2,486  527 4- 82 
* 104 T  cells were incubated with 5  x  105 irradiated spleen cells. Back- 
ground proliferation on B10 spleen cells was: clone BC4,  831  +  199; 
clone BC6, 558 +  187; clone BC8, 439 -_- 86. 
* The indicated antibodies were added at initiation of cultures at a final 
concentration of 1:500. 
Monoclona] antibody 10-3.6. 
I  Monoclonal antibody 14-4-4S,  recognizing specificity Ia.7. 434  T  CELL  SPECIFICITY  AND  ALLOREACTIVITY 
alloreactive clones, BC4, was subcloned by limiting dilution at 0.3 cells per well. 
Two groups of subciones were raised. The first group was subcloned with B10- 
irradiated spleen cells and cow insulin;  the second group  was subcloned with 
irradiated PL/J cells. All (9/9 are shown here; a total of 16 were tested) display 
corecognition and allorecognition specificities identical to the parent clone (Table 
IV). 
To further define the stimulating determinant on PL/J cells, the B 10 congenic 
of PL/J,  B10.PL,  was tested. This strain has MHC genes derived from PL/J, 
but all  non-MHC genes derived from C57BL/10.  Cells from this strain  were 
ineffective at stimulating PL/J reactive clones (Table V). 
To test for the involvement of MHC gene products in this allogeneic response, 
monoclonai antibodies to the two class II MHC molecules of PL/J, i.e., to I-A" 
and I-E" (13), were tested for their effects on PL/J recognition (Tables VI and 
VII). Anti-I-A" has no effect on the response to PL/J. Antibody 14-4-4S, which 
reacts with the Ia.7 specificity of the I-E  u molecule, inhibits recognition of PL/J 
cells by alloreactive anti-insulin clones; responses of the clones to syngeneic B 10 
spleen cells plus cow insulin are unaffected by this antibody. Conversely, anti-I- 
A b antibody inhibits responses to syngeneic spleen cells and cow insulin but has 
no effect on the response to PL/J cells. Finally, an anti-I-E that sees a private 
specificity  of  I-E  k  but  is  unreactive  with  I-E"  has  no  effect  on  alloantigen 
recognition (Table  VI).  This  same fine specificity for I-E  u of PL/J  mice was 
demonstrated for all ailoreactive B 10 anti-cow insulin clones. Furthermore, the 
small but significant response to SM/J cells (H-2 v) is also inhibited by anti-Ia.7 
antibody,  indicating that  a  determinant of the  I-E  molecule is  recognized by 
these clones, and the inhibition is not due to a  coincidental cross-reactivity of 
this antibody to PL/J spleen cells (Table VII). 
Discussion 
It is clear from previous studies that at least some T  cells express receptors 
both for corecognition of autologous MHC products plus antigen as well as for 
alloantigens (6, 8,  10,  11). Two major views have been advanced to explain the 
molecular and genetic basis for a  cell's ability to recognize these two types of 
MHC  molecules.  The  first  holds  that  corecognition  and  allorecognition  are 
mediated by distinct and independent gene products expressed on the cell (9). 
According to  this  idea,  continuous  stimulation  of an  individual's  T  cells  by 
environmental antigens would not bias the repertoire for polymorphic variants 
of MHC  products.  The alternative view is  that alloreactivity is  due to  cross- 
reactive recognition of alloantigens and autologous MHC molecules plus conven- 
tional antigen, and this  reflects molecular mimicry between polymorphic and 
somatic  variants  of  MHC  products  (6,  7).  The  latter,  but  not  the  former, 
hypothesis predicts that  the fine specificity of a  cell for conventional antigen 
associated  with  autologous  MHC  products  will  dictate  its  specificity for cells 
bearing foreign MHC product. 
To distinguish between these alternatives, we compared alloreactivity patterns 
of T  cell clones specific for identical epitopes on the insulin molecule. Although 
a  similar  study  has  been  previously reported,  the  precise  specificities of the 
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such as ovalbumin display many different potentially immunogenic epitopes to 
cells from BALB/c mice. Clones reactive to different epitopes on this glycopro- 
tein can thus exhibit apparently random reactions toward foreign MHC products, 
as was found in that report. Moreover, in our hands stimulation of BALB/c cells 
with  ovalbumin  frequently generates  cells  that  corecognize proteins  in  FCS 
associated with a  foreign haplotype (Suzan Friedman, unpublished data).  It is 
therefore critical to establish (a) a panel of clones that corecognize one epitope 
and self-Ia and (b) to define alloreactivity in the absence of calf serum proteins. 
Analysis of a panel of clones specific for a unique amino acid sequence on the 
cow insulin molecule and a self-MHC product revealed that a substantial fraction 
of these clones (products of separate T  cell stimulation experiments) reacted to 
one particular foreign MHC product: I-E  u from PL/J mice. All these reactions 
were  independent  of serum  used  to  supplement  the  cultures.  These  results 
indicate that the gene product(s) that recognizes complexes of MHC products 
and conventional antigen ("Ia +  X") also recognizes MHC products that mimic 
this complex. The similarity between complexes of I-A  b and cow insulin, on the 
one hand, and I-E  u from PL/J mice, is not obvious. 
These results do not formally exclude the possibility that the gene product(s) 
that recognizes alloantigen differs from the gene product(s) that corecognizes 
MHC-antigen  complexes.  First,  expression  of the two gene products  may be 
coordinately controlled in clones of inducer cells. There is no information on 
the sequences coding for T  cell receptors, nor is there precedent for coordinate 
expression of two different V regions in B lymphocytes. Second, other panels of 
inducer T  clones with defined specificity for a  particular conventional antigen 
must be tested for selective alloreactivity to establish whether the results reported 
here represent a general rule rather than an adventitious cross-reactivity. 
If recognition of both  sets of antigens is due to a  single receptor or set of 
receptors, the finding that 50% of B 10 anti-cow insulin clones are alloreactive to 
PL/J and that 50% are not implies the existence of two different receptors or 
possibly two different gene products that recognize a very limited sequence on 
the  cow  insulin  molecule.  We  have  recently developed antibodies  that  bind 
strongly and specifically to all anti-A-loop/PL/J-reactive clones but do not bind 
to anti-A-loop nonalloreactive clones. These antibodies completely inhibit the 
responses of the anti-A-loop alloreactive clones to both cow insulin and PL/J 
but have no effect on the anti-cow insulin responses of the nonalloreactive clones. 
This reagent should define the molecular relationship of the anti-A-loop and 
anti-PL/J receptor(s). 
Classic studies that established the high frequency of alloreactive T  lympho- 
cytes (1, 2) used noncongenic strains of rodents and thus measured ailoreactivity 
to MHC gene products as well as complexes of these gene products with other 
cell  surface molecules.  Analogous  studies  using  congenic mice and  stringent 
controls for specificity of cellular activation (other than lymphokine production) 
are needed to quantitate the frequencies of T  cells that recognize MHC gene 
products alone and those that recognize them associated with other cell surface 
molecules. The alloreaction described here may be an example of the latter type 
of recognition.  The  difference  between  PL/J  and  B10.PL  with  respect  to 
activation of these clones is not apparent from these studies.  One possibility is 436  T  CELL SPECIFICITY AND ALLOREACTIVITY 
that a non-MHC gene product of PL/J may move freely in the membrane and 
interact  with  I-E molecules such that  the two determinants  form one antigenic 
unit.  Another  possibility  is  that  I-E  is  the  sole  molecule  recognized  by these 
clones.  In  this  case,  expression  of the  I-E gene product on B10.PL and  PL/J 
may  differ  due  to  glycosylation  differences  dictated  by  non-MHC-encoded 
enzymes or because of a mutation that may have occurred during the backcross- 
ing of this MHC haplotype onto the B10 background. 
In sum, these results show that, at least for some T  cells, expression of genes 
that dictate receptors for conventional antigen-Ia complexes and for alloantigens 
is not independent.  They support the view that some reactions to foreign MHC 
products  reflect  molecular  mimicry:  foreign  MHC  products  that  successfully 
mimic the structure of an antigen-Ia complex recognized by an inducer cell will 
stimulate that T  clonefl Further studies of other panels of inducer clones will be 
necessary to determine  whether  the  fine specificity of corecognition  routinely 
predicts the specificity of alloreactivity. 
Summary 
We have analyzed a panel of T  cell clones that corecognize defined epitopes 
of the insulin molecule in association with Ia for their patterns of recognition of 
alloantigens.  A striking correlation  is observed between recognition of the I-A  b 
gene product and  cow insulin  alpha  loop and  recognition  of I-E  u of the  PL/J 
haplotype. These results are consistent with the notion that reactions to foreign 
major histocompatibility complex (MHC) products reflect molecular mimicry by 
foreign class II antigens  of 'physiologic' complexes formed by autologous class 
II MHC molecules and antigen. 
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